Chennai Meenakshi Multispeciality Hospital Limited has released its unaudited financial results for the quarter and nine months ended December 31, 2025, showing a mixed performance with revenue growth but continued losses.

Financial Performance Overview

The hospital reported total income from operations of ₹937.96 lakhs for the third quarter of FY26, representing an increase from ₹909.31 lakhs in the corresponding quarter of the previous year. However, this was lower than the previous quarter's performance of ₹980.85 lakhs.

Nine-Month Performance

For the nine-month period ended December 31, 2025, Chennai Meenakshi Multispeciality Hospital Limited demonstrated improved performance compared to the previous year. Total income from operations reached ₹2810.70 lakhs, up from ₹2608.10 lakhs in the corresponding nine-month period of the previous year.

Earnings Per Share and Capital Structure

The company's equity share capital remained stable at ₹746.89 lakhs with a face value of ₹10 per share. The basic and diluted earnings per share for Q3 FY26 stood at negative ₹0.72, compared to negative ₹0.84 in the corresponding quarter of the previous year.

Corporate Governance and Compliance

The financial results were reviewed and recommended by the Audit Committee and subsequently approved by the Board of Directors at their meeting held on February 11, 2026. The results have been published in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The complete financial results along with the Limited Review Report are available on the stock exchange website ( www.bseindia.com ) and the company's website ( www.cmmh.in ). The hospital, formerly known as Devaki Hospital Limited, operates from its registered office at Luz Church Road, Mylapore, Chennai, and maintains ISO 9001:2008 and ISO 14001:2004 certifications.

Chennai meenakshi multispeciality Hospital Limited has announced its unaudited financial results for the third quarter ended December 31, 2025, showing a net loss of ₹54.06 lakhs compared to ₹62.95 lakhs loss in the corresponding quarter of the previous fiscal year. Despite the continued losses, the company demonstrated revenue growth and improved operational metrics during the reporting period.

Financial Performance Overview

The hospital's financial performance for Q3 FY26 showed mixed results with revenue growth but persistent losses:

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the company showed significant improvement in loss reduction:

Expense Structure and Operational Metrics

The company's expense breakdown for Q3 FY26 revealed the following cost structure:

• Employee benefits expenses: ₹263.38 lakhs (26.52% of total expenses)
• Other expenses: ₹491.04 lakhs (49.43% of total expenses)
• Purchase of stock-in-trade: ₹188.41 lakhs (18.97% of total expenses)
• Depreciation and amortisation: ₹26.75 lakhs
• Finance costs: ₹22.13 lakhs

The company maintained its equity share capital at ₹746.89 lakhs with a face value of ₹10 per share throughout the reporting periods.

Board Approval and Compliance

The Board of Directors approved these unaudited financial results at their meeting held on February 11, 2026. The meeting commenced at 12:00 hours and concluded at 16:00 hours. The financial results were prepared in accordance with Indian Accounting Standard 34 'Interim Financial Reporting' and comply with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Auditor Review and Corporate Governance

The statutory auditors, Elias George & Co., Chartered Accountants, conducted a limited review of the financial results. The results were reviewed and recommended for adoption by the Audit Committee before Board approval. The company operates in a single business segment related to healthcare services and maintains its registered office at Luz Church Road, Mylapore, Chennai.